Article
Medicine, General & Internal
Dong Yoon Han, Myung-Won You, Chi Hyuk Oh, Seong Jin Park
Summary: This study analyzed the long-term disease course and factors leading to poor prognosis in patients with Crohn's disease. It found that some patients had complicated and relapsing disease courses, and 2-year disease characteristics were significant factors for predicting poor prognosis.
Article
Clinical Neurology
Yasuyuki Kinoshita, Akira Taguchi, Fumiyuki Yamasaki, Atsushi Tominaga, Kazunori Arita, Nobutaka Horie
Summary: This retrospective study examined the natural course of Rathke's cleft cysts (RCCs) and identified the risk factors for their progression. The results showed that 10% of RCCs progressed, 31.9% spontaneously regressed, and the remaining 133 RCCs remained stable. Older age and initially presenting symptom of acute headache were associated with increased risk of RCC progression and spontaneous regression, respectively.
JOURNAL OF NEUROSURGERY
(2023)
Article
Gastroenterology & Hepatology
Ohad Atia, Ben Kang, Esther Orlansky-Meyer, Oren Ledder, Raffi Lev Tzion, Sujin Choi, Byung-Ho Choe, Youra Kang, Dotan Yogev, Hisham Najara, Natalie Carmon, Gili Focht, Eyal Shteyer, Dan Turner
Summary: This study examined the accuracy of three predictive models for pediatric Crohn's disease (CD) and found that none of them achieved sufficient accuracy. This highlights the necessity of external validation before implementing any predictive model in clinical practice.
JOURNAL OF CROHNS & COLITIS
(2022)
Article
Medicine, General & Internal
Eun Ae Kang, Jongha Jang, Chang Hwan Choi, Sang Bum Kang, Ki Bae Bang, Tae Oh Kim, Geom Seog Seo, Jae Myung Cha, Jaeyoung Chun, Yunho Jung, Hyun Gun Kim, Jong Pil Im, Sangsoo Kim, Kwang Sung Ahn, Chang Kyun Lee, Hyo Jong Kim, Min Suk Kim, Dong Il Park
Summary: By combining genetic polymorphisms and clinical features, it is possible to more accurately predict the need for early intestinal resection in CD patients. The study found that age and disease behavior were key clinical parameters for predicting early surgery, while four specific SNPs also played important roles in the prediction.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Gastroenterology & Hepatology
Prathyush Chirra, Anamay Sharma, Kaustav Bera, H. Matthew Cohn, Jacob A. Kurowski, Katelin Amann, Marco-Jose Rivero, Anant Madabhushi, Cheng Lu, Rajmohan Paspulati, Sharon L. Stein, Jeffrey A. Katz, Satish E. Viswanath, Maneesh Dave
Summary: Radiomic features extracted from magnetic resonance enterography are associated with the need for surgery in Crohn's disease patients at risk of complications, and when combined with clinical variables and radiological assessment, they can accurately predict the time to surgery.
INFLAMMATORY BOWEL DISEASES
(2023)
Article
Clinical Neurology
Ri-Miao Yang, Fang-Bin Hao, Bo Zhao, Qian Zhang, Dan Yu, Zheng-Xing Zou, Gan Gao, Qing-Bao Guo, Xu-Xuan Shen, He-Guan Fu, Si-Meng Liu, Min-Jie Wang, Jing-Jie Li, Cong Han
Summary: This study aimed to investigate the natural course and risk factors of moyamoya disease (MMD) with unruptured intracranial aneurysms. Through observations of 42 patients with MMD, it was found that the risk of aneurysm rupture and hemorrhage is low. The progression of Suzuki stage in MMD may be associated with the shrinkage or disappearance of aneurysms.
FRONTIERS IN NEUROLOGY
(2023)
Article
Gastroenterology & Hepatology
Manuela Distante, Silvia Rotulo, Marco Ranalli, Eugenio Pedace, Paolo Lionetti, Serena Arrigo, Patrizia Alvisi, Erasmo Miele, Massimo Martinelli, Giovanna Zuin, Matteo Bramuzzo, Mara Cananzi, Marina Aloi
Summary: This study aimed to define clusters of disease activity and prognostic factors of disease course in a well-characterized cohort of children with Crohn's disease (CD). During the first 5 years of follow-up, one-third of children with CD experience a quiescent course. Surgery at the diagnosis is related to a quiescent course, while growth impairment and lack of response to induction therapy correlate with more severe disease activity during follow-up.
INFLAMMATORY BOWEL DISEASES
(2023)
Review
Gastroenterology & Hepatology
Choong Wui Cho, Myung-Won You, Chi Hyuk Oh, Chang Kyun Lee, Sung Kyoung Moon
Summary: Crohn's disease is a chronic inflammatory bowel disease that affects young people and has a heterogeneous clinical course, including four patterns: remission, stable disease, chronic relapsing disease, and chronic refractory disease. Understanding the long-term disease course is crucial for revealing underlying pathophysiology and achieving more optimistic outcomes.
Article
Gastroenterology & Hepatology
Samuel Sassine, Lisa Djani, Christine Cambron-Asselin, Mathieu Savoie, Yi Fan Lin, Marwa Qaddouri, Souhila Zekhnine, Kelly Grzywacz, Veronique Groleau, Martha Dirks, Eric Drouin, Ugur Halac, Valerie Marchand, Chloe Girard, Olivier Courbette, Natalie Patey, Dorothee Dal Soglio, Colette Deslandres, Prevost Jantchou
Summary: Relapse of pediatric Crohn's disease is significantly associated with clinical, endoscopic, histological, and laboratory variables as well as treatment strategies. The relapse rate has decreased over the past decade.
AMERICAN JOURNAL OF GASTROENTEROLOGY
(2022)
Article
Gastroenterology & Hepatology
Feng Xia, Qiao Zhang, Jun Zheng, Zhiyuan Huang, Elijah Ndhlovu, Hengyi Gao
Summary: This study establishes a clinical model to predict R1 resection after hepatectomy for resectable ruptured hepatocellular carcinoma (rHCC), which can be used to better plan perioperative strategies.
JOURNAL OF GASTROINTESTINAL SURGERY
(2023)
Article
Parasitology
Jie Yin, Xiaoxu Wu, Chenlu Li, Jiatong Han, Hongxu Xiang
Summary: This study investigated the spatial distribution and environmental determinants of human echinococcosis in western China. The analysis revealed hot spots in certain regions, with relative humidity, altitude, and grassland area ratio being identified as key factors influencing the prevalence of echinococcosis. Prevention and control measures were found to be effective in reducing the disease's prevalence. The spatial epidemiological modelling methods used in this study can be helpful in future research on echinococcosis and similar diseases.
PARASITES & VECTORS
(2022)
Article
Clinical Neurology
Hao Feng, Xin Wang, Wenjuan Wang, Xingquan Zhao
Summary: This study identified the risk factors and constructed a prediction model for poor prognosis and mortality in patients with intracerebral hemorrhage (ICH) at discharge, 3 months, and 12 months. The prediction models for prognosis showed a relatively high predictive performance.
FRONTIERS IN NEUROLOGY
(2023)
Article
Pharmacology & Pharmacy
Jingrong Weng, Xutao Lin, Xi Chen, Yu-fan Liang, Yu-cheng Xu, Jia-wei Cai, Peng-cheng Lu, Yuming Rong, Yifeng Zou, Lixin Zhu
Summary: This study found that the prognosis of L4-EGD phenotype may be better than that of the Non-L4-EGD phenotype in patients with Crohn's disease.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Gastroenterology & Hepatology
Peter De Cruz, Amy L. Hamilton, Kathryn J. Burrell, Alexandra Gorelik, Danny Liew, Michael A. Kamm
Summary: The study found that the combination of ulcer depth and circumference at the anastomosis at 6 months postoperatively was associated with endoscopic recurrence at 18 months. Based on these two parameters, a POCER postoperative index was established to identify patients who may require more intensive therapy.
INFLAMMATORY BOWEL DISEASES
(2022)
Article
Health Care Sciences & Services
Esmee Venema, Benjamin S. Wessler, Jessica K. Paulus, Rehab Salah, Gowri Raman, Lester Y. Leung, Benjamin C. Koethe, Jason Nelson, Jinny G. Park, David van Klaveren, Ewout W. Steyerberg, David M. Kent
Summary: PROBAST and its shorter version can effectively identify poorly performing clinical prediction models, high ROB is prevalent among published CPMs and is associated with poor discriminative performance at validation.
JOURNAL OF CLINICAL EPIDEMIOLOGY
(2021)
Article
Gastroenterology & Hepatology
Jae-Young Lee, Hyun Woo Ma, Ji Hyung Kim, I. Seul Park, Mijeong Son, Keun Ho Ryu, Jieun Shin, Seung Won Kim, Jae Hee Cheon
Summary: The study found that CKD-506 has anti-inflammatory effects on PBMCs and CD4+ T cells, and improves gut barrier function. These findings suggest that CKD-506 may be a potential small molecule therapeutic option for inflammatory bowel disease.
Article
Biotechnology & Applied Microbiology
Hyun Woo Ma, Jung Min Kim, Da Hye Kim, I. Seul Park, Ji Hyung Kim, Ki Cheong Park, Dong Hyuk Seo, Jae Hyeon Kim, Xiumei Che, Tae Il Kim, Jae Hee Cheon, Seung Won Kim
Summary: This study investigated the role of OLFM4 in colorectal cancer (CRC) and found that it plays different regulatory roles in tumor development and metastasis.
CANCER GENE THERAPY
(2023)
Article
Gastroenterology & Hepatology
Jae Hee Cheon, Hyun-Soo Kim, Dong Soo Han, Sung Kook Kim, Sung Jae Shin, Joo Sung Kim, Byong Duk Ye, Geun Am Song, YoungJa Lee, Youngdoe Kim, Yoosun Lee, Won Ho Kim
Summary: This study provides evidence that infliximab is effective and well-tolerated in patients with moderate-to-severe active intestinal Behcet's disease.
Article
Gastroenterology & Hepatology
Kyuwon Kim, Kookhwan Choi, Sung Wook Hwang, Jong Pil Im, Byong Duk Ye, Joo Sung Kim, Kyu Joo Park, Suk-Kyun Yang, Seong-Joon Koh, Sang Hyoung Park
Summary: CD-associated SBA did not differ in overall survival from sporadic SBA, but CD is an independent risk factor for mortality.
Article
Nutrition & Dietetics
Jung Hyun Kwak, Chang Soo Eun, Dong Soo Han, Yong Sung Kim, Kyu Sang Song, Bo Youl Choi, Hyun Ja Kim
Summary: This study evaluated the association of individual or a combination of protective foods on the incidence of gastric cancer in H. pylori-positive subjects. Results showed that a higher intake of soy products and fruits was associated with a lower risk of gastric cancer. Additionally, the combination of soy products or fruits with dairy products also reduced the risk of gastric cancer.
NUTRITION RESEARCH AND PRACTICE
(2023)
Article
Chemistry, Multidisciplinary
Gyu Hwan Hyun, Da-Hye Jeong, Yoon Young Yang, In Ho Cho, Yu-Jin Ha, Xiaohui Xing, D. Wade Abbott, Yves S. Y. Hsieh, Yun Pyo Kang, Jong-Ho Cha, Soon-Sun Hong, Seul Ji Lee, You-Sun Kim, Sung Won Kwon
Summary: Current cancer immunotherapeutic strategies mainly focus on remodeling the tumor microenvironment (TME) to make it favorable for antitumor immunity. A galactan-enriched nanocomposite (Gal-NC) has been developed as a carbohydrate nanoadjuvant with a macrophage-targeting feature, which can effectively restore and enhance the weakened antitumor immunity. Gal-NC mediates Toll-like receptor 4 (TLR4) activation, inducing the repolarization of tumor-associated macrophages (TAMs) towards immunostimulatory/tumoricidal M1-like phenotypes, leading to increased intratumoral population of cytotoxic T cells and synergistically enhancing T-cell-mediated antitumor response.
Article
Gastroenterology & Hepatology
Seung Won Kim, Jae-Young Lee, Han Cheol Lee, Jae Bum Ahn, Ji Hyung Kim, I. Seul Park, Jae Hee Cheon, Duk Hwan Kim
Summary: HSP72 is an important mediator in fibrosis of Crohn's disease, regulating myofibroblasts and epithelial-mesenchymal transition, and could be a target for antifibrotic therapy.
Article
Gastroenterology & Hepatology
I. Seul Park, Ji Hyung Kim, Jongwook Yu, YooJin Shin, Kibeom Kim, Tae Il Kim, Seung Won Kim, Jae Hee Cheon
Summary: This study investigated the mechanisms of action of B. breve CBT BR3 in relieving colitis. The results showed that B. breve CBT BR3 improved colitis symptoms, increased the number of goblet cells, and protected inflammation-induced epithelial cell permeability. It also enhanced the expressions of tight-junction protein and proteins related to butyrate metabolism.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(2023)
Editorial Material
Gastroenterology & Hepatology
Jun Su Lee, Sang-Bum Kang, Kwangbeom Park, Yong Sik Yoon, Chang Sik Yu, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Jong Lyul Lee, Sang Hyoung Park
INTESTINAL RESEARCH
(2023)
Correction
Gastroenterology & Hepatology
Kyunghwan Oh, Hee Seung Hong, Nam Seok Ham, Jungbok Lee, Sang Hyoung Park, Suk-Kyun Yang, Hyuk Yoon, You Sun Kim, Chang Hwan Choi, Byong Duk Ye
INTESTINAL RESEARCH
(2023)
Article
Gastroenterology & Hepatology
Kyuwon Kim, Sojung Park, Yoonho Lee, Jiwon Baek, Yongjae Kim, Sung Wook Hwang, Jong Lyul Lee, Sang Hyoung Park, Suk-Kyun Yang, Buhm Han, Kyuyoung Song, Yong Sik Yoon, Ho-Su Lee, Byong Duk Ye
Summary: This study investigated the transcriptional profile and compositional features of creeping fat (CF) in Crohn's disease (CD). The results showed that CF in CD patients had a large number of genes related to immune cell responses, while genes with a decremental pattern were associated with cell migration. Cell analysis revealed significant changes in cellular composition between CD-CF and Con-MAT groups.
JOURNAL OF CROHNS & COLITIS
(2023)
Article
Gastroenterology & Hepatology
Suhyun Park, Jae Yong Lee, Seung Wook Hong, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon
Summary: This study aimed to investigate the effect of stenting-related factors, including endoscopists' expertise, on clinical outcomes after bridge-to-surgery (BTS) stenting for obstructive colorectal cancer (CRC). The results showed that the expertise of endoscopists was associated with better short-term outcomes, including high stenting success rate and low rate of stent-related complications after BTS stenting. The interval between stenting and surgery also played a role in postoperative complications.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(2023)
Review
Gastroenterology & Hepatology
You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko
Summary: Primary sclerosing cholangitis (PSC), strongly associated with inflammatory bowel disease (IBD), is a progressive disease characterized by cholestasis, inflammation, and fibrosis. PSC-IBD represents a unique entity with increased risk of malignancy, including colorectal cancer and cholangiocarcinoma. Despite advancements, no effective medical therapy has significantly impacted PSC prognosis. Treatment options for PSC-IBD are the same as for PSC alone, but potential drugs targeting bile acids, inflammation, fibrosis, and gut dysbiosis have been developed. This review summarizes current medical treatments and emerging therapeutic agents for PSC-IBD.
INTESTINAL RESEARCH
(2023)